Skip to content

Imaging features of gray ultrasound and shear-wave elastography for improving the accuracy of breast US and identifying malignancy and predicting subtype of breast cancer

Imaging features of gray ultrasound and shear-wave elastography for improving the accuracy of breast US and identifying malignancy and predicting subtype of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016072
Enrollment
Unknown
Registered
2018-05-09
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Lesion pathology biopsy
gray&#32
ultrasound&#32
(US)&#32
and&#32
imaging

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with a US-visible breast mass were recruited from the First Affiliated Hospital of Zhengzhou University. Eligible patients will be woman aged 19 years and older with a breast mass revealed with palpation, mammography, US, or magnetic resonance imaging who were referred for breast US. And lesions with pathological results categorized as BI-RADS category 3,4,5 at US evaluation.

Exclusion criteria

Exclusion criteria: Women with breast implants and those who were pregnant or lactating, who were receiving chemotherapy or radiation therapy for any cancer, who had a history of ipsilateral breast surgery, or who were unwilling or unable to provide informed consent were excluded. We also excluded skin lesions, lesions that had been biopsied previously, lesions that were pure calcifications with no mass. Only a single mass was included from each participant in this analysis, with preference to including malignant lesions: If there was more than one malignant lesion in a given participant, then one was selected at random. If there were no malignancies, but multiple benign or high-risk lesions in a given participant, then one benign or high-risk lesion was randomly selected. Specifically, benign and malignant lesions were each sorted in random order for each participant, and the first malignant lesion was chosen, or, if there were no malignancies, then the first benign lesion was selected.

Design outcomes

Primary

MeasureTime frame
Emax;Emean;Emin;Size;Gray ultrasound;

Countries

China

Contacts

Public ContactRuifang Zhang

The First Affiliated Hospital of Zhengzhou University

zhangruifang999@hotmail.com+86 13663824995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026